F-1
filed
Initial foreign registration statement
Initial public filing for a foreign issuer submitted to start the SEC review process.
First tracked pre-IPO filing for this issuer.
Chungui International BioTech Group Co., Ltd. is conducting its initial public offering (IPO) of 3,000,000 ordinary shares on the Nasdaq Capital Market under the symbol CQFT. The company, structured as a Cayman Islands holding company with operations in Mainland China, faces regulatory and operational risks tied to Chinese laws, including cybersecurity reviews, anti-monopoly enforcement, and potential U.S. trading restrictions under the HFCAA. It has filed with the CSRC for overseas listing compliance and is classified as an emerging growth company with reduced reporting requirements.
2026-03-12 · 0001099910-26-000110